MA44947A1 - Antibodies and anti-vista fragments - Google Patents
Antibodies and anti-vista fragmentsInfo
- Publication number
- MA44947A1 MA44947A1 MA44947A MA44947A MA44947A1 MA 44947 A1 MA44947 A1 MA 44947A1 MA 44947 A MA44947 A MA 44947A MA 44947 A MA44947 A MA 44947A MA 44947 A1 MA44947 A1 MA 44947A1
- Authority
- MA
- Morocco
- Prior art keywords
- antibodies
- vista
- fragments
- methods
- vista fragments
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 abstract 1
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne de nouveaux anticorps et des fragments qui se lient à un suppresseur ig à domaine v de l'activation lymphocytaire t (vista,), et des procédés de préparation et d'utilisation de ceux-ci. L'invention concerne également des méthodes de traitement du cancer, y compris les leucémies, les lymphomes, les tumeurs solides et les mélanomes.The present invention provides novel antibodies and fragments which bind to a v-domain ig suppressor of t-cell activation (vista,), and methods of preparation and use thereof. The invention also relates to methods of treating cancer, including leukemias, lymphomas, solid tumors, and melanomas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361920695P | 2013-12-24 | 2013-12-24 | |
| PCT/IB2014/002868 WO2015097536A2 (en) | 2013-12-24 | 2014-12-22 | Anti-vista antibodies and fragments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA44947A1 true MA44947A1 (en) | 2019-11-29 |
| MA44947B1 MA44947B1 (en) | 2020-05-29 |
Family
ID=61730504
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39210A MA39210A1 (en) | 2013-12-24 | 2014-12-22 | Antibodies and anti-vista fragments |
| MA44947A MA44947B1 (en) | 2013-12-24 | 2014-12-22 | Antibodies and anti-vista fragments |
| MA51179A MA51179A1 (en) | 2013-12-24 | 2020-09-22 | Antibodies and anti-vista fragments |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39210A MA39210A1 (en) | 2013-12-24 | 2014-12-22 | Antibodies and anti-vista fragments |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51179A MA51179A1 (en) | 2013-12-24 | 2020-09-22 | Antibodies and anti-vista fragments |
Country Status (1)
| Country | Link |
|---|---|
| MA (3) | MA39210A1 (en) |
-
2014
- 2014-12-22 MA MA39210A patent/MA39210A1/en unknown
- 2014-12-22 MA MA44947A patent/MA44947B1/en unknown
-
2020
- 2020-09-22 MA MA51179A patent/MA51179A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA39210A1 (en) | 2018-02-28 |
| MA44947B1 (en) | 2020-05-29 |
| MA51179A1 (en) | 2021-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201691323A1 (en) | ANTI-VISTA ANTIBODIES AND FRAGMENTS | |
| TN2019000099A1 (en) | ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS | |
| MX2023005053A (en) | Psma ligands for imaging and endoradiotherapy. | |
| MA40513A (en) | DRUG-ANTIBODY ANTI-CDH6 CONJUGATES | |
| MA53356B1 (en) | Subcutaneous anti-cd38 antibody formulations and uses thereof | |
| MA40576A (en) | ANTIBODIES AND IMMUNOCONJUGATES ANTI-HER2 | |
| MA39095A1 (en) | Anti-cd33 antibodies and immunoconjugates | |
| FR3021970B1 (en) | ANTIBODY AGAINST GALECTIN 9 AND INHIBITOR OF THE SUPPRESSIVE ACTIVITY OF T REGULATORY LYMPHOCYTES | |
| MA50949B1 (en) | ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF | |
| MA44659B1 (en) | ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS | |
| MA38632A1 (en) | Anti-transferrin receptor antibody and methods of use | |
| MA49726B1 (en) | ANTI-CGRP ANTIBODY FORMULATION | |
| EA201890158A1 (en) | ANTIBODIES AGAINST NTB-A AND RELATED COMPOSITIONS AND METHODS | |
| EA201500393A1 (en) | BLUTON TYROSINKINASE INHIBITORS | |
| MA40682A (en) | ANTI-OX40 ANTIBODIES AND CORRESPONDING METHODS OF USE | |
| TR201911139T4 (en) | Cytotoxic and anti-mitotic compounds and methods of using them. | |
| MA38986B1 (en) | Protein specific membrane antigen (psma) labeled inhibitors, their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| MA38925B1 (en) | Substituted phenylalanine derivatives | |
| JOP20150008B1 (en) | Anti-vista antibodies and fragments | |
| MA45831B1 (en) | ANTI-BEDBUG MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF | |
| MA51179A1 (en) | Antibodies and anti-vista fragments | |
| MA39355A1 (en) | Anti-ox40 antibodies and methods of use thereof | |
| JOP20200184B1 (en) | VISTA antibodies and parts thereof | |
| MA38159A1 (en) | Isolated antibodies that bind to the bcma antigen used to treat cancers, eg, b-cell cancer and multiple myeloma | |
| MA38492A1 (en) | Antibodies and anti-b7-h4 immunoconjugates |